Science
Zihai Li: Targeting TGFβ Docking Receptor GARP via CAR-T Cell Platform to Treat Glioblastoma
Zihai Li/X

Zihai Li: Targeting TGFβ Docking Receptor GARP via CAR-T Cell Platform to Treat Glioblastoma

Zihai Li, Professor and Founding Director at the Pelotonia Institute for Immuno-Oncology, shared a post on X about a paper published on Neuro-Oncology:

“This is our preclinical work on targeting TGFβ docking receptor GARP via CAR-T cell platform to treat glioblastoma Our clinical trial is actively enrolling pts. Many thanks to all authors and collaborators to make it possible.”

Title: Targeting TGFβ docking receptor Glycoprotein A Repetitions Predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma

Authors: Bill Xingjun Wu , Daniel Kreatsoulas , Hakan Cam , Chelsea Bolyard , Yuzhou Chang , Jay Mandula , Parker W Welsh , Ziyu Wang , Anqi Li , Payton Weltge , J Bradley Elder , Pierre Giglio , Jose J Otero , Prajwal Rajappa , Damien Gerald , Dongjun Chung , Qin Ma , Maria Velegraki , Zihai Li

Read the full article.

Zihai Li: Targeting TGFβ Docking Receptor GARP via CAR-T Cell Platform to Treat Glioblastoma

More posts featuring Zihai Li on OncoDaily.

Anqi Li Bill Xingjun Wu cancer CAR T-CELL Chelsea Bolyard Damien Gerald Daniel Kreatsoulas Dongjun Chung glioblastoma Hakan Cam J Bradley Elder Jay Mandula Jose J Otero Maria Velegraki Neuro-Oncology OncoDaily Oncology Parker W Welsh Payton Weltge Pierre Giglio Prajwal Rajappa Qin Ma TGFβ Yuzhou Chang Zihai Li Zihai Li i Ziyu Wang